“…Little disagreement exists regarding whether residents in institutional settings should receive influenza antiviral chemoprophylaxis in the context of an institutional influenza outbreak. Observational data [151,195,197,198,[217][218][219][220][221] evidence from randomized trials [219,222] and recommendations from influenza experts and medical societies [5,94,188,206,211,223,224] support the use of influenza antivirals for residents in this setting. Instituting chemoprophylaxis also demonstrates economic benefit for the affected facility [225].…”